Pricing
  1. US-listed companies
  2. Lunai Bioworks Inc.
  3. Financials
  4. Cash from operations

Lunai Bioworks Inc.【LNAI】

Market cap
$31.74M
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Jun 30, 2024-11-6.82%
Jun 30, 2023-12-25.16%
Jun 30, 2022-16-23.67%
Jun 30, 2021-21+142.27%
Jun 30, 2019-9+96.10%
Jun 30, 2018-4+268.44%
Jun 30, 2017-1-20.02%
Jun 30, 2016-1-27.62%
Dec 31, 2014-2+6659.85%
Mar 31, 2013-0+20.63%
Mar 31, 2012-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)